AHR and endometriosis: Collectively, these findings suggest that interventions targeting the tryptophan–AhR axis—such as probiotics, prebiotics, IDO-1 inhibitors, and AhR modulators—represent a promising, non-hormonal approach to managing endometriosis through microbiome-based immunomodulation [65].